The main goal of this research project is to study if a protein named SEMA3C can be a biomarker for early detection of an aggressive and lethal form of prostate cancer, named Double Negative Prostate Cancer (DNPC). To test if SEMA3C is a contributing factor in the progression of DNPC, we will compare SEMA3C level […]
Read More